
GHW International
9933.HKHKSEBasic MaterialsChemicals - Specialty
Latest quote
HK$1.68
+HK$0.005 · +0.30%
9933.HK company overview
Regular session · HKT · Market data may be delayed.
Company profile
Company websiteGHW International is an investment holding company that manufactures and globally distributes a variety of chemical and pharmaceutical products. Its operations reach across the People's Republic of China, Europe, Vietnam, other Asian regions, and various international markets. The company organizes its business into four primary divisions: Polyurethane Materials, Animal Nutrition Chemicals, Fine Chemicals, and Pharmaceutical Products and Intermediates. The Polyurethane Materials division supplies polymeric methylene diphenyl diisocyanate (PMDI), toluene diisocyanate (TDI), and polymer polyether, which are integral to the production of cushion foams, vehicle interior components, and other lightweight automotive parts. Its Animal Nutrition Chemicals segment provides choline chloride and betaine, essential compounds used in feed formulations for poultry and livestock. The Fine Chemicals division produces various substances, including carboxylic acids, solvents, resins, and oleochemicals. These find applications in paints, dye synthesis, lubricant manufacturing, emulsifiers, cosmetics, flavors, fragrances, and feed additives. Lastly, the Pharmaceutical Products and Intermediates segment manufactures and markets compounds like isooctanoic acid and diethyl sulfate. These are utilized as paint driers, fungicides, preservatives, and pharmaceutical raw materials, as well as in the synthesis of dyes, pesticides, and pharmaceutical intermediates. This segment also offers iodine and its derivatives, along with finished pharmaceutical products, such as cefpodoxime dispersible tablets. GHW International was established in 1995 and its main offices are situated in Nanjing, People's Republic of China.
- Industry
- Chemicals - Specialty
- Sector
- Basic Materials
- Headquarters
- CN
- CEO
- Yanbin Yin
- Listed since
- Jan 21, 2020
- Employees
- 1,109
Market position
52-week range
Current HK$1.68
- Open
- HK$1.68
- Previous close
- HK$1.675
- Volume
- 28K
- 0.13× average
- Average volume
- 215.78K
- Average daily volume
- Market cap
- 1.59B HKD
- Beta
- 0.56
- Market reference 1
- 50-day average
- HK$1.5993
- +5.05% above average
- 200-day average
- HK$1.6688
- +0.67% above average
Financials
Financial snapshot
Latest / TTMValuation & yield
- Enterprise value
- 2.27B CNY
- P/E (TTM)
- 106.67×
- P/B (TTM)
- 2.27×
- P/S (TTM)
- 0.33×
- EV / EBITDA
- 59.21×
- Earnings yield
- 0.80%
- Free cash flow yield
- 6.03%
- Dividend yield
- 0.00%
Profitability & efficiency
- Gross margin
- 8.77%
- Operating margin
- 0.54%
- Net margin
- 0.31%
- Return on equity
- 2.12%
- Return on assets
- 0.61%
- Return on invested capital
- 1.13%
Financial health
- Debt / equity
- 1.43×
- Current ratio
- 0.93×
- Altman Z-score
- 4.73
- Piotroski F-score
- 7 of 9
Financial statements
Margin trends
Profitability as a percentage of reported revenue.
Income trends
Revenue
Operating income
Net income
| Metric (CNY) | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 4.11B CNY | 3.86B CNY | 3.22B CNY | 3.38B CNY | 2.83B CNY |
| Cost of goods sold | 3.75B CNY | 3.47B CNY | 2.88B CNY | 2.72B CNY | 2.36B CNY |
| Gross profit | 360.87M CNY | 391.02M CNY | 336.98M CNY | 657.9M CNY | 476.12M CNY |
| Research and development | 57.15M CNY | 48.86M CNY | 75.24M CNY | 77.29M CNY | 59.15M CNY |
| Selling, general, and administrative | 283.85M CNY | 310.36M CNY | 256.32M CNY | 257.48M CNY | 244.96M CNY |
| Operating expenses | 338.64M CNY | 359.48M CNY | 327.51M CNY | 317.8M CNY | 306.48M CNY |
| Interest income | 1.99M CNY | 2.25M CNY | 2.32M CNY | 4.91M CNY | 6.25M CNY |
| Interest expense | 36.32M CNY | 39.91M CNY | 39.21M CNY | 36.99M CNY | 29.83M CNY |
| Depreciation and amortization | 16.18M CNY | 7.87M CNY | 7.87M CNY | 6.31M CNY | 4.11M CNY |
| Operating income | 22.22M CNY | 31.55M CNY | 9.47M CNY | 323.13M CNY | 172M CNY |
| Net income | 12.72M CNY | 12.75M CNY | 2.72M CNY | 274.63M CNY | 130.71M CNY |
Company facts updated Aug 24, 2026.
Earnings
- Latest EPS result
- 0.01
EPS: actual versus estimate
Recent quarterly results
Revenue: actual versus estimate
Recent quarterly results
9933.HK peers
Continue in GoAI
Research 9933.HKresearch.disclaimer





